Delivery Order SPE2DB20D1100-SPE2DB25FE1BE
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Droxidopa 100 mg capsules (90-count) on April 30, 2025, with a ceiling value of $4,010.25 and an ultimate completion date of May 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Droxidopa is a neurological medication used primarily to treat symptomatic...
- The Defense Logistics Agency awarded a delivery order valued at $34,442.65 to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Droxidopa 100 mg capsules (90-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Droxidopa 200 mg capsules (90-count units) valued at $25,920.22. This firm fixed-price delivery order, awarded on August 20, 2025, represents a competitive award with no set-aside designation and an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. Droxidopa is a neurological medication used to treat...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Droxidopa 100 mg capsules (90-count unit). This competitive award, valued at $14,943.40, is structured as a firm fixed price delivery order with a completion date of September 9, 2025. The contract was not designated as a set-aside and represents a procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Droxidopa 200 mg capsules (90-count units) with a ceiling value of $146,485.30. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The performance location is established at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) at a ceiling value of $1,266.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,203.90 to AmerisourceBergen Drug Corp for the supply of Droxidopa 100 mg capsules (90-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's...
- This delivery order, awarded on September 25, 2025, requires AmerisourceBergen Drug Corp to supply 90-count bottles of Droxidopa 100 mg capsules to the Defense Health Agency's Medical Supply Chain, a Defense Department organization. The contract is valued at $5,190.16 with a firm fixed price structure and an ultimate completion date of September 26, 2025. The award was made without any set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's...
- This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
- The Defense Logistics Agency awarded a $29,180.36 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 90 capsules of the drug NORTHERA (droxidopa) 300 mg under contract number 4561478986. The place of performance will be DMS Pharmaceutical's facility located in Park Ridge, Illinois. The period of performance is July 10, 2023 through July 31, 2023. As the DLA supports procurement for the Department of Defense, this delivery order is likely fulfilling medical supply needs for...